Fidelman Nicholas, Bloom Allan I, Kerlan Robert K, Laberge Jeanne M, Wilson Mark W, Ring Ernest J, Gordon Roy L
Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Room M-361, San Francisco, CA 94143, USA.
Radiology. 2008 Jun;247(3):880-6. doi: 10.1148/radiol.2473070529.
To retrospectively determine if patients with a history of intraoperative bile duct injury or liver transplantation have an increased risk for arterial injury (AI) during percutaneous transhepatic cholangiography (PTC) and percutaneous transhepatic biliary drainage (PTBD) compared with the risk of AI established in the 1970s and 1980s.
This study was approved by the committee on human research and was deemed compliant with the Health Insurance Portability and Accountability Act. The informed consent requirement was waived. Records of 1394 procedures (307 PTCs, 1087 PTBDs) performed in 930 patients (445 male, 485 female; age range, 4 months to 99 years) over the past 13 years were retrospectively reviewed. The rate of AI was determined, and demographic, pathologic, technical, and laboratory variables were tested for association with increased risk of AI by using generalized estimating equation analysis.
AIs were encountered after 30 (2.2%) biliary procedures. No significant difference in the rate of AI was seen among the groups of patients with malignant biliary obstruction (1.8%), history of bile duct injury (2.2%), or complications of liver transplantation (2.6%). Patients who underwent PTBD had a higher risk of AI than did patients who underwent PTC (2.6% vs 0.7%); however, this difference was not significant (P = .06). Ongoing hemobilia was seen in 26 (87%) of the patients, which made it the most common sign of AI, and it had a 94% positive predictive value for AI. A postprocedure decrease in the hematocrit level of more than 13% was seen only in the setting of AI, and it occurred in only three (10%) of patients with AIs.
PTC and PTBD performed for management of bile duct injury and complications of liver transplantation are not associated with an increased risk of hepatic AIs compared with the risk of AI reported in the 1970s and 1980s.
回顾性确定与20世纪70年代和80年代确定的动脉损伤(AI)风险相比,有术中胆管损伤或肝移植病史的患者在经皮经肝胆管造影(PTC)和经皮经肝胆道引流(PTBD)期间发生AI的风险是否增加。
本研究经人体研究委员会批准,并被认为符合《健康保险流通与责任法案》。豁免了知情同意要求。回顾性分析了过去13年中930例患者(445例男性,485例女性;年龄范围4个月至99岁)进行的1394例手术记录(307例PTC,1087例PTBD)。确定AI发生率,并使用广义估计方程分析测试人口统计学、病理学、技术和实验室变量与AI风险增加的相关性。
30例(2.2%)胆道手术中出现AI。恶性胆管梗阻患者组(1.8%)、胆管损伤病史患者组(2.2%)或肝移植并发症患者组(2.6%)的AI发生率无显著差异。接受PTBD的患者发生AI的风险高于接受PTC的患者(2.6%对0.7%);然而,这种差异不显著(P = 0.06)。26例(87%)患者出现持续性胆道出血,这使其成为AI最常见的体征,对AI的阳性预测值为94%。仅在AI情况下观察到术后血细胞比容水平下降超过13%,且仅在3例(10%)AI患者中出现。
与20世纪70年代和80年代报道的AI风险相比,为处理胆管损伤和肝移植并发症而进行的PTC和PTBD与肝AI风险增加无关。